Methodology

All entries for: nNOS U.S. Inc.

September 3, 2025

nNOS U.S. Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of malignant glioma

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top